| 1 |
26304864 | Deferoxamine, Cerebrovascular Hemodynamics, and Vascular Aging: Potential Role for Hypoxia-Inducible Transcription Factor-1-Regulated Pathways. | 2015 Sep |
1 |
| 2 |
14733417 | Comparative study of intravenous ascorbic acid versus low-dose desferroxamine in patients on hemodialysis with hyperferritinemia. | 2003 Sep-Oct |
1 |
| 3 |
11973424 | Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. | 2002 May |
2 |
| 4 |
10926654 | Effects of desferrioxamine on serum erythropoietin and ventilatory sensitivity to hypoxia in humans. | 2000 Aug |
5 |
| 5 |
9927288 | Effects of pro- and antioxidative compounds on renal production of erythropoietin. | 1999 Feb |
2 |
| 6 |
10356310 | Regulation of erythropoietin gene expression depends on two different oxygen-sensing mechanisms. | 1999 Jun |
1 |
| 7 |
10422630 | Erythropoietin production: evidence for multiple oxygen sensing pathways. | 1999 Jun |
4 |
| 8 |
9804609 | Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity. | 1998 Nov |
1 |
| 9 |
9027727 | Cobalt and desferrioxamine reveal crucial members of the oxygen sensing pathway in HepG2 cells. | 1997 Feb |
2 |
| 10 |
9027728 | Cobalt chloride and desferrioxamine antagonize the inhibition of erythropoietin production by reactive oxygen species. | 1997 Feb |
3 |
| 11 |
9115299 | Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. | 1997 May 2 |
2 |
| 12 |
8853224 | Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis. | 1996 |
1 |
| 13 |
8904876 | Iron deprivation increases erythropoietin production in vitro, in normal subjects and patients with malignancy. | 1996 Nov |
3 |
| 14 |
7628592 | Treatment of erythropoietin-resistant anaemia with desferrioxamine in patients on haemofiltration. | 1995 Aug |
1 |
| 15 |
8260699 | Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. | 1993 Dec 15 |
4 |
| 16 |
8450906 | Direct effect of deferoxamine on hemoglobin synthesis in patients on hemodialysis treated with recombinant human erythropoietin. | 1993 |
1 |
| 17 |
8506193 | Resistance to recombinant human erythropoietin due to aluminium overload and its reversal by low dose desferrioxamine therapy. | 1993 Feb |
2 |
| 18 |
1857480 | Desferrioxamine enhances the haemopoietic response to erythropoietin, but adverse events are common. | 1991 |
1 |
| 19 |
1934678 | Erythropoietin and improvement in the erythropoiesis of chronic hemodialysis patients treated with desferrioxamine. | 1991 Sep |
1 |
| 20 |
2809506 | Beneficial effects of erythropoietin on haematological parameters, aerobic capacity, and body fluid composition in patients on haemodialysis. | 1989 Nov |
1 |